238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
View analysts' price targets and recommendations, and compare them with competitors.
$187.00
Analysts expect the stock price to decrease by 22.34%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
392.21B
The estimated revenue has increased from the previous period.
133.42B
The estimated EBITDA has increased from the previous period.
9.00
The estimated EPS has increased from the previous period.
109.58B
The estimated net income has increased from the previous period.
111.25B
The estimated EBIT has increased from the previous period.
60.17B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
506.29B
Revenue has increased from the previous period.
18.10%
Revenue growth rate is unchanged from the previous period.
172.23B
EBITDA has increased from the previous period.
34.02%
EBITDA margin is unchanged from the previous period.
143.61B
EBIT has increased from the previous period.
28.36%
EBIT margin is unchanged from the previous period.
28.62B
Depreciation has increased from the previous period.
282.85B
Total cash has increased from the previous period.
55.87%
Cash percentage is unchanged from the previous period.
80.27B
Receivables have increased from the previous period.
15.85%
Receivables percentage is unchanged from the previous period.
2.44B
Inventories have increased from the previous period.
0.48%
Inventory percentage is unchanged from the previous period.
13.26B
Accounts payable has increased from the previous period.
2.62%
Payables percentage is unchanged from the previous period.
-58.67B
Capital expenditure has increased from the previous period.
-11.59%
CapEx percentage is unchanged from the previous period.
9.08%
WACC is unchanged from the previous period.
9.14%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.03
Beta is unchanged from the previous period.
12.72B
Diluted shares outstanding is unchanged from the previous period.
28.50B
Total debt is unchanged from the previous period.
2.49T
Total equity is unchanged from the previous period.
2.51T
Total capital is unchanged from the previous period.
1.13%
Debt weighting is unchanged from the previous period.
98.87%
Equity weighting is unchanged from the previous period.
121.89B
EBIAT has increased from the previous period.
81.19B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
2.32T
Terminal value is unchanged from the previous period.
1.82T
Enterprise value is unchanged from the previous period.
4.46B
Net debt is unchanged from the previous period.
1.81T
Equity value is unchanged from the previous period.
142.33
Equity value per share is unchanged from the previous period.
